- Merck Still Plans To Win Big Cost Savings This Year From Schering-Plough Deal (Health News Daily)
This is copyright protected information, to receive the full article, please click here to sign up and register.
- Strides Arcolab Looking to Expand Pfizer Supply Pact (The Wall Street Journal)
- AstraZeneca settles with Teva over generic Nexium (PharmaTimes)
- OraSure Technologies Files Additional Data With FDA in Support of PMA Application for OraQuick Rapid HCV Test (CNN Money)
- Canada Lends Mexico 5 Million Doses Of H1N1 Vaccine (AHN)
- Novartis Buys Majority Stake in Alcon (PharmaTech)
- Almirall, Forest celebrate promising COPD drug data (PharmaTimes)
- Olay Highlights P&G’s Push to Extend Brands (The Wall Street Journal)
- A Hypertension Drug Requiring Less-Frequent Dosing Than Novartis’s Diovan/Tareg Would Earn Similar Patient Share in Europe and U.S. (PR Newswire)
- Pfizer and Debiopharm To Conduct Trial Of Melanoma Treatment (CNN Money)
- FDA Review Recommends Against Forest Drug For Heart Failure (The Wall Street Journal)
SUBSCRIBE